VENTURE CAPITAL, NASHVILLE
Funding Healthcare Forward
FCA Venture Partners backs founders reshaping how care is delivered, financed, and experienced. With over 50 portfolio companies and deep domain expertise across providers, payers, pharma, and innovative care delivery, we deploy capital where it drives the greatest clinical and commercial impact.
The Origin Story
Built on Conviction.
Proven by Portfolio.
FCA Venture Partners was founded on a single thesis. Technology-enabled solutions are the most powerful lever for transforming healthcare at scale. Over years of active investing, FCA Venture Partners has deployed capital across more than 50 high-conviction positions, partnering with founders who are reengineering care pathways, improving payer efficiencies, accelerating drug development, and pioneering new models of care delivery.
Our track record is not incidental. It is the product of disciplined sector focus, proprietary deal flow, and a network built at the intersection of clinical, operational, and financial expertise.
EST. 1996 • NASHVILLE, TN
"We Invest in Structural Change, Not Surface-Level Disruption."
At FCA Venture Partners, our investment philosophy is grounded in a fundamental belief. Sustainable healthcare transformation requires solutions that address root-cause inefficiencies, not incremental workarounds. We prioritize companies with defensible technology moats, scalable go-to-market strategies, and founding teams with deep domain fluency in the healthcare ecosystem.
We look for ventures where clinical outcomes and financial returns are aligned, not in tension. That means backing platforms capable of moving the needle on total cost of care, quality metrics, and patient access simultaneously, and doing so in ways that survive the regulatory, reimbursement, and procurement realities of the healthcare market.
Four Verticals. One Integrated Thesis.
FCA Venture Partners has built concentrated expertise and a high-value operator network across the four sectors driving healthcare's structural transformation.
Providers
Backing technology that reduces administrative burden, improves clinical decision-making, and enables value-based care models at health systems, physician groups, and ambulatory networks.
Payers
Investing in platforms that drive utilization management, member engagement, risk stratification, and claims intelligence for commercial, Medicare Advantage, and Medicaid plans.
Pharma
Supporting solutions in drug discovery, real-world evidence, patient identification, and commercial enablement that accelerate time-to-market and improve therapeutic outcomes.
Innovative Care Delivery
Partnering with founders building next-generation care models, from virtual-first primary care to specialty-focused value-based organizations, that expand access and realign financial incentives.
Building Something That Can Transform Healthcare?
FCA Venture Partners is actively deploying capital into early and growth-stage healthcare technology companies across providers, payers, pharma, and innovative care delivery.
Whether you're raising a seed round or a Series B, if your company is positioned to drive measurable clinical and financial impact, we want to hear from you.